EM1421, Erimos’ candidate anti-cancer drug


Guests: Dr. Neil Frazer, COO, and Jean Chitwood, Vice President, Commercial, Erimos Pharmaceuticals, Raleigh

frazerphotocompressed.jpg
Dr. Neil Frazer, Chief Operating Officer, Erimos Pharmaceuticals
chitwoodphotocompressed.jpg
Jean Chitwood, Vice President, Commercial, Erimos Pharmaceuticals

Erimos Pharmaceuticals home page

Dose Escalation Study of EM-1421 for the Treatment of Recurrent or Refractory Solid Tumors (clinical trial of Erimos’ candidate compound)

ClinicalTrials.gov – comprehensive site for information on privately and federally supported clinical research in human volunteers

Click to Download: Radio In Vivo August 23, 2006